Literature DB >> 769214

Cessation of immunosuppression after renal transplantation.

D T Uehling, J L Hussey, A B Weinstein, R Wank, F H Bach.   

Abstract

Five recipients of successful living related donor kidney transplants stopped azathioprine and prednisone against medical advice. Two recipients who were nonidentical by human leukocyte (HL-A) serotyping and mixed leukocyte culture (MLC) became uremic again after cessation if immunosuppression for periods of 2 and 6 months. Both patients died while refusing to reinstitute iunosuppression and their kidneys showed severe rejection histologically. Three recipients of MCL and HL-A identical kidneys were off azathioprine and prednisone for periods of 7, 12, and 30 months, respectively. None developed changes in renal function. Two patients currently are back on immunosuppression. The third recipient remains stable although off immunosuppression for 36 months; her cessation of immunosuppression was elicited by a mailed questionnaire sent to all recipients following detection of the first four. In addition to these five patients, three recipients of cadaver kidneys lost graft function after lapses in immunosuppression. This represents a 4% incidence of major lapses in immunosuppression (excluding known cessation during sepsis). The clinical outcome depended on degree of histocompatibility as best measured by MLC.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769214

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

Authors:  Pervinder Sagoo; Esperanza Perucha; Birgit Sawitzki; Stefan Tomiuk; David A Stephens; Patrick Miqueu; Stephanie Chapman; Ligia Craciun; Ruhena Sergeant; Sophie Brouard; Flavia Rovis; Elvira Jimenez; Amany Ballow; Magali Giral; Irene Rebollo-Mesa; Alain Le Moine; Cecile Braudeau; Rachel Hilton; Bernhard Gerstmayer; Katarzyna Bourcier; Adnan Sharif; Magdalena Krajewska; Graham M Lord; Ian Roberts; Michel Goldman; Kathryn J Wood; Kenneth Newell; Vicki Seyfert-Margolis; Anthony N Warrens; Uwe Janssen; Hans-Dieter Volk; Jean-Paul Soulillou; Maria P Hernandez-Fuentes; Robert I Lechler
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Ultra-localization of Foxp3+ T cells within renal allografts shows infiltration of tubules mimicking rejection.

Authors:  Kathryn Brown; Victoria Moxham; Julieta Karegli; Richard Phillips; Steven H Sacks; Wilson Wong
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

Review 3.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

4.  Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.

Authors:  D Berglund; M Karlsson; A-R Biglarnia; T Lorant; G Tufveson; O Korsgren; B Carlsson
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

5.  HLA-A, -B, and -DR zero-mismatched kidneys shipped to the University of Wisconsin, Madison, 1993-2006: superior graft survival despite longer preservation time.

Authors:  William J Burlingham; Alejandro Muñoz del Rio; David Lorentzen; Hans W Sollinger; John D Pirsch; Ewa Jankowska-Gan; Anthony D'Alessandro
Journal:  Transplantation       Date:  2010-08-15       Impact factor: 4.939

Review 6.  Development of tolerogenic strategies in the clinic.

Authors:  Stuart J Knechtle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

7.  Human allograft acceptance is associated with immune regulation.

Authors:  A M VanBuskirk; W J Burlingham; E Jankowska-Gan; T Chin; S Kusaka; F Geissler; R P Pelletier; C G Orosz
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 8.  Clinical operational tolerance after renal transplantation: current status and future challenges.

Authors:  Giuseppe Orlando; Peiman Hematti; Robert J Stratta; George W Burke; Pierpaolo Di Cocco; Pierpaolo Di Cocco; Francesco Pisani; Shay Soker; Kathryn Wood
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

9.  Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.

Authors:  D P Singal; M A Blajchman; S Joseph; B Roberge; E K Smith; D Ludwin
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

10.  Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance.

Authors:  Junchao Cai; Junglim Lee; Ewa Jankowska-Gan; Richard Derks; Jos Pool; Tuna Mutis; Els Goulmy; William J Burlingham
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.